Generics - Teva Pharmaceutical Industries, Cardio-vascular

Filter

Popular Filters

US Appeals Court reverses 2012 decision on Lovaza, clearing way for generics

13-09-2013

Reversing a district court decision last year (The Pharma Letter May 30, 2012), the US Court of Appeals…

AmarinCardio-vascularGenericsGlaxoSmithKlineLegalLovazaNorth AmericaPar PharmaceuticalsPatentsPharmaceuticalTeva Pharmaceutical IndustriesVascepa

Teva launches generic Aprovel in UK

30-08-2012

The UK subsidiary of Israel's Teva Pharmaceutical Industries (NYSE: TEVA), the world's largest generic…

AprovelBristol-Myers SquibbCardio-vascularEuropeGenericsMarkets & MarketingSanofiTeva Pharmaceutical Industries

EU Commission focus now on Servier and others re-perindopril antitrust issues

31-07-2012

The European Commission has informed French independent pharmaceutical company Servier and several of…

Cardio-vascularEuropeGenericsLegalMarkets & MarketingMylan LaboratoriesPatentsperindoprilPharmaceuticalServierTeva Pharmaceutical Industries

USA FDA approves ANDAs for Plan B One-Step and Trandate

16-07-2012

Watson Pharmaceuticals (NYSE: WPI) says its subsidiary Watson Laboratories approval from the US Food…

Cardio-vascularGenericsNorth AmericaPar PharmaceuticalsPlan B One-StepRegulationReproductiveTeva Pharmaceutical IndustriesTrandateWatson Pharmaceuticals

Teva debuts generic of Provigil, Avapro and Avalide; Ranbaxy Crestor copy OKed in Canada

01-04-2012

Israeli generics giant Teva Pharmaceutical Industries (Nasdaq: TEVA) last Friday launched an authorized…

AstraZenecaAvalideAvaproCardio-vascularCephalonCrestorDaiichi SankyoGenericsMarkets & MarketingNeurologicalNorth AmericaProvigilRanbaxy LaboratoriesRegulationSanofiTeva Pharmaceutical Industries

Forest files suit over Bystolic patent; generic Lexapro launched in USA

15-03-2012

US drugmaker Forest Laboratories (NYSE: FRX) and Janssen Pharmaceutica, a unit of health care giant Johnson…

BystolicCardio-vascularForest LaboratoriesGenericsJanssen PharmaceuticaJohnson & JohnsonLexaproNeurologicalNorth AmericaPatentsRegulationTeva Pharmaceutical IndustriesWatson Pharmaceuticals

Watson and Ranbaxy kick off genericization of Lipitor, launching their approved copies in USA

01-12-2011

US generic drug major Watson Pharmaceuticals (NYSE: WPI) was the first to confirm yesterday that it has…

atorvastatinCardio-vascularGenericsLipitorMarkets & MarketingNorth AmericaPfizerPharmaceuticalRanbaxy LaboratoriesTeva Pharmaceutical IndustriesWatson Pharmaceuticals

Company Spotlight

ImmunoGen

ImmunoGen

Back to top